Hereditary Angioedema (HAE) Consensus Document

A WAO Symposium of the HAE International Alliance during the XXII World Allergy Congress (WAC 2011) in Cancun, Mexico, 6 December 2011

Welcoming Remarks by the Chairpersons
TIMOTHY J. CRAIG: Penn State University, Milton S. Hershey Medical Center; Hershey, Pennsylvania, USA
MICHIHIRO HIDE: Hiroshima University of Medicine, Department of Dermatology; Minami-ku, Hiroshima, Japan



Summary of the Document
Presented by: Timothy J. Craig
Professor of Medicine and Pediatrics
Distinguished Educator
Chief, Allergy, Asthma and Immunology
Program Director
Director of Clinical Allergy and Respiratory Research
Pennsylvania State University College of Medicine
Milton S. Hershey Medical Center
Hershey, Pennsylvania, USA
Learning Objectives:

1. To produce an evidence based guideline for care of HAE patients throughout the world
   
2. Develop a document that would be a reference for HCP; develop a document that could be used at the bedside
   
3. Have a document that could be utilized in all countries
   
4. Develop a guideline that would be approved by the global allergy community
   
5. Develop a power point program for use by all members of the WAO
   
6. Lastly, and most importantly, to improve care for the patients with Hereditary Angioedema and to improve access of therapies to all patients, in all countries around the world

---

Pathogenesis
Presented by: Michael M. Frank
Samuel Katz Professor of Pediatrics, Medicine and Immunology
Duke University Medical Center
Durham, North Carolina, USA
Learning Objectives:

1. Understand the molecular basis for C1 inhibitor deficiency in HAE
   
2. Understand why C1 inhibitor deficiency results in angioedema

---

Clinical Presentation
Presented by: Marco Cicardi
Department Scienze Cliniche Luigi Sacco
Universita di Milano
Ospedale L.Sacco
Milano, Italy
Learning Objectives:

In recent years treatment of HAE has radically changed since new drugs arrived on the market. Recognizing the clinical picture of this disease has thus become even more important than in the past in order to provide patients with the appropriate therapeutic approach.

---

New Approaches to Treatment
Presented by: Aleena Banerji
Clinical Immunology/Allergy Unit
Massachusetts General Hospital
Boston, Massachusetts, USA
Learning Objectives:

1. Discuss novel treatment options for hereditary angioedema
   
2. Review consensus guidelines for the treatment of hereditary angioedema
   
3. Compare long-term prophylaxis vs on-demand treatment
   
4. Discuss the benefits of self-administration for patients

Handouts
Handouts for this session are available from the WAC 2011 scientific program online.
Visit the Hereditary Angioedema (HAE) International Alliance online.



The video recording of this WAO Symposium was supported through an unrestricted educational grant from CSL Behring.





WAO Contact Information
World Allergy Organization
555 East Wells Street, Suite 1100
Milwaukee, Wisconsin 53202-3823 USA
Phone: +1-414-276-1791 Fax: +1-414-276-3349
E-mail:info@worldallergy.org
Internet: www.worldallergy.org